177 related articles for article (PubMed ID: 17476196)
21. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
22. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
[TBL] [Abstract][Full Text] [Related]
23. Urinary zinc excretion and zinc status of patients with beta-thalassemia major.
Aydinok Y; Coker C; Kavakli K; Polat A; Nisli G; Cetiner N; Kantar M; Cetingül N
Biol Trace Elem Res; 1999 Nov; 70(2):165-72. PubMed ID: 10535525
[TBL] [Abstract][Full Text] [Related]
24. Zinc status affects glucose homeostasis and insulin secretion in patients with thalassemia.
Fung EB; Gildengorin G; Talwar S; Hagar L; Lal A
Nutrients; 2015 Jun; 7(6):4296-307. PubMed ID: 26043030
[TBL] [Abstract][Full Text] [Related]
25. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion.
Soliman AT; el Banna N; alSalmi I; Asfour M
J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961
[TBL] [Abstract][Full Text] [Related]
26. The oral glucose tolerance test is frequently abnormal in patients with uncontrolled epilepsy.
Vianna JB; Atallah AN; Prado GF; Valente O; Duarte-Barros ML; Vianna EC; Mello LE
Epilepsy Behav; 2006 Aug; 9(1):140-4. PubMed ID: 16774846
[TBL] [Abstract][Full Text] [Related]
27. Zinc in thalassemic patients and its relation with depression.
Moafi A; Mobaraki G; Taheri SS; Heidarzadeh A; Shahabi I; Majidi F
Biol Trace Elem Res; 2008; 123(1-3):8-13. PubMed ID: 18338112
[TBL] [Abstract][Full Text] [Related]
28. [Beta-cell secretion in patients with thalassemia major].
Massolo F; Forese S; Gallinelli A; Bergomi A; Cellini M; Iori G; Leoni S; Amarri S
Minerva Pediatr; 1995 Mar; 47(3):57-64. PubMed ID: 7791713
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant micronutrients in children with thalassaemia in Egypt.
Nasr MR; Ali S; Shaker M; Elgabry E
East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
[TBL] [Abstract][Full Text] [Related]
30. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
[TBL] [Abstract][Full Text] [Related]
31. The continuous glucose monitoring system (CGMS) in patients with beta-thalassemia major and impaired glucose homeostasis: preliminary results.
Rimondi F; Banin P; Gamberini MR; De Sanctis V
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():190-2. PubMed ID: 19337177
[TBL] [Abstract][Full Text] [Related]
32. Factors determining glucose tolerance in patients with thalassemia major.
Dmochowski K; Finegood DT; Francombe W; Tyler B; Zinman B
J Clin Endocrinol Metab; 1993 Aug; 77(2):478-83. PubMed ID: 8345055
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia.
Gorodetsky R; Goldfarb A; Dagan I; Rachmilewitz EA
J Lab Clin Med; 1985 Jan; 105(1):44-51. PubMed ID: 3968464
[TBL] [Abstract][Full Text] [Related]
34. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
35. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
36. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
Au WY; Lam WW; Chu W; Tam S; Wong WK; Liang R; Ha SY
Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
[TBL] [Abstract][Full Text] [Related]
37. Bone metabolism and mineral density in patients with beta-thalassemia major.
Dundar U; Kupesiz A; Ozdem S; Gilgil E; Tuncer T; Yesilipek A; Gultekin M
Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
39. Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution.
Haugaard SB; Andersen O; Halsall I; Iversen J; Hales CN; Madsbad S
Metabolism; 2007 Jul; 56(7):939-46. PubMed ID: 17570256
[TBL] [Abstract][Full Text] [Related]
40. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
